3 completed, 2 active not recruiting. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Active not recruiting 2 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Camurus AB: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD CAM2029, Placebo - Polycystic Liver Disease | Phase 2 / Phase 3 | Active not recruiting | Camurus AB | 71 | 2022-06-28 | 2026-06-01 |
| A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET CAM2029, Octreotide LAR, Lanreotide ATG - Gastro-enteropancreatic Neuroendocrine Tumor | Phase 3 | Active not recruiting | Camurus AB | 332 | 2021-10-22 | 2026-07-28 |
| A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly CAM2029 (octreotide subcutaneous depot) - Acromegaly | Phase 3 | Completed | Camurus AB | 135 | 2019-10-10 | 2025-12-22 |
| A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly CAM2029 (octreotide subcutaneous depot), Matching placebo - Acromegaly | Phase 3 | Completed | Camurus AB | 72 | 2019-08-19 | 2026-08-20 |
| Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain buprenorphine, Placebo - Chronic Lower Back Pain, Chronic Pain | Phase 3 | Completed | Braeburn Pharmaceuticals | 1053 | 2016-09-01 | 2021-10-15 |
Acromegaly (2) · Chronic Pain (1) · Gastro-enteropancreatic neuroendocrine tumor (1) · Polycystic Kidney, Autosomal Dominant (1) · Polycystic liver disease (1)
Buprenorphine (1)
United States (5) · Germany (4) · Hungary (3) · Italy (3) · Spain (3) · Belgium (2) · Greece (2) · Netherlands (2) · Poland (2) · Russia (2) · Turkey (Türkiye) (2) · United Kingdom (2) · Australia (1) · Canada (1) · France (1)
Diego Ferone, M.D (1) · Joost Drenth, MD (1) · Pamela Freda, M.D (1) · Simron Singh, MD, MPH (1)
PMID 40418492, PMID 38229199, PMID 39356039, PMID 39378125
2019 (2), 2023 (1)